CP 532,623

Known as: CP532623, CP-532623, CP 532623 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
0120092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Lipid based formulations (LBFs) are a promising formulation strategy for many poorly water-soluble drugs and have been shown… (More)
Is this relevant?
2014
2014
The present study investigated the use of lipid based drug delivery systems to enhance the oral bioavailability of the CETP… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
To evaluate the potential role of intestinal lymphatic transport in the absorption and oral bioavailability of members of an… (More)
  • table I
  • figure 1
  • table II
  • table III
  • figure 2
Is this relevant?
2010
2010
To explore the mechanism of lymphatic access of the CETP inhibitors (CETPi) CP524,515 and CP532,623 and probe their potential… (More)
  • table I
  • table II
  • figure 1
  • table III
  • figure 2
Is this relevant?
2009
2009
ILLUMINATE, the phase 3 morbidity and mortality trial of the cholesteryl ester transfer protein (CETP) inhibitor, torcetrapib… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?